Human herpesvirus-6 in liver transplant recipients: Role in pathogenesis of fungal infections, neurologic complications, and outcome

Transplantation

Volumn 69, Issue 12, 2000, Pages 2566-2573

  Rogers, Jeffrey ^a   Rohal, Susan ^a   Carrigan, Donald R ^c   Kusne, Shimon ^a   Knox, Konstance K ^c   Gayowski, Timothy ^a,b   Wagener, Marilyn M ^b   Fung, John J ^a,b   Singh, Nina ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Wisconsin Viral Research Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; HUMAN; HUMAN HERPESVIRUS 6; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; MYCOSIS; PRIORITY JOURNAL; SEROLOGY; VIREMIA; VIRUS CULTURE; VIRUS DETECTION; VIRUS ISOLATION;

EID: 0034720716     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200006270-00016     Document Type: Article

References (43)

1. Salahuddin SZ, Ablashi DV, Markham PD, Josephs SF, Sturzenegger S, Kaplan M. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986; 234: 596.
2. Biberfeld P, Kramarsky B, Salahuddin SZ, Gallo RC. Ultrastructural characterization of a new human B lymphotropic DNA virus (human herpesvirus 6) and human cytomegalovirus. J Natl Cancer Inst 1987; 79: 933.
3. Kimberlin DW. Human herpesviruses 6 and 7: identification of newly recognized viral pathogens and their association with human disease. Pediatr Infect Dis J 1998; 17: 59.
4. Singh N, Carrigan DR. Human herpesvirus-6 in transplantation: an emerging pathogen. Ann Intern Med 1996; 124: 1065.
5. Okuno T, Higashi K, Shirak K, Yamanishi K, Takahashi M, Kokado Y, et al. Human herpesvirus 6 infection in renal transplantation. Transplantation 1990; 49: 519.
6. Yoshikawa T, Suga S, Asano Y, Nakashima T, Yazaki T, Ono Y, et al. A prospective study of human herpesvirus-6 infection in renal transplantation. Transplantation 1992; 54: 879.
7. Herbein G, Strasswimmer J, Altieri M, Woehl-Jaegle ML, Wolfe P, Obert G. Longitudinal study of human herpesvirus-6 in organ transplant recipients. Clin Infect Dis 1996; 22: 171.
8. Carrigan DR. Human herpesvirus-6 and bone marrow transplantation [Letter]. Blood 1995; 85: 294.
9. Chou SW, Scott KM. Rises in antibody to human herpesvirus 6 detected by enzyme immunoassay in transplant patients with primary cytomegalovirus infection. J Clin Microbiol 1990; 28: 851.
10. Carrigan DR, Knox KK. Human herpesvirus-6 in transplantation: pathogenesis and diagnosis. Curr Opin Organ Transplant 1999. In press.
11. Lautenschlager I, Hockerstedt K, Linnavuori K, Taskinen E. Human herpesvirus-6 infection after liver transplantation. Clin Infect Dis 1998; 26: 702.
12. Yoshikawa T, Ihira M, Furukawa H, Suga S, Asonuma K, Tanaka K, et al. Four cases of human herpesvirus-6 variant B infection after pediatric liver transplantation. Transplantation 1998; 65: 1266.
13. Singh N, Carrigan DR, Gayowski T, Marino IR. Human herpesvirus-6 infection in liver transplant recipients: documentation of pathogenicity. Transplantation 1997; 64: 674.
14. Carrigan DR, Milburn G, Dlenglewicz R, Kernen N, Papadopoulias E, Singh N. Diagnosis of active human herpesvirus six (HHV-6) infections in immunosuppression and patients with rapid shell-vial assay [Abstract]. In: Abstracts of the 96th General Meeting of the American Society for Microbiology, New Orleans, American Society for Microbiology, 1996.
15. Singh N, Yu VL, Mieles L, Wagener MM, Miner RC, Gayowski T. High-dose ayclovir compared with short-course preemptive ganciclovir therapy to prevent cytomegalovirus disease in liver transplant recipients, a randomized trial. Ann Intern Med 1994; 120: 375.
16. Kusne S, Grossi P, Irish W, St.George K, Rinaldo C, Rakela J, et al. Cytomegalovirus PP65 antigenemia monitoring as a guide for preemptive therapy: a cost effective strategy for prevention of cytomegalovirus disease in adult liver transplant recipients. Transplantation 1999; 68: 1125.
17. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions of nosocomial infections. Am J Infect Control 1988; 16: 128.
18. Kusne S, Dummer JS, Singh N, Iwatsuki S, Makowka L, Esquivel C, et al. Infections after liver transplantation, an analysis of 101 consecutive cases. Medicine 1988; 67: 132.
19. Chang FY, Singh N, Gayowski T, Wagener MM, Marino IR. Fever in liver transplant recipients in the 1990's: Changing spectrum of etiologic agents. Clin Infect Dis; 26:59.
20. Moschettini D, De Milito A, Catucci M, Marconi A, Rinina C, Bianchi-Bandinelli ML, et al. Detection of human herpesviruses 6 and 7 in heart transplant recipients by a multiplex polymerase chain reaction method. Eur J Clin Microbiol Infect Dis 1998; 17: 117.
21. Osman HKE, Peiris JSM, Taylor CE, Warwicker P, Jarrett RF, Madeley CR. Cytomegalovirus disease in renal allograft recipients: is human herpesvirus-7 a cofactor for disease progression? J Med Virol 1996; 48: 295.
22. Schmidt CA, Wilborn F, Weiss K, Brinkman V, Oettle H, Lohmann R, et al. A prospective study of human herpesvirus type 6 detected by polymerase chain reaction after liver transplantation. Transplantation 1996; 61: 662.
23. Pasquinelli C, Laure F, Chatenoud L, Beaurain G, Gazengel C, Bismuth H, et al. Hepatitis B virus DNA in mononuclear blood cells: a frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease. J Hepatol 1986; 3: 95.
24. Kadakia MP, Rybka WB, Stewart JA, Patton JL, Stamey FR, Elsawy M, et al. Human herpesvirus 6: infection and disease following autologous and allogeneic bone marrow transplantation. Blood 1996; 87: 5341.
25. Suga S, Yoshikawa T, Asano Y, Nakashima T, Kobayashi I, Yazaki T. Activation of human herpesvirus-6 in children with acute measles. J Med Virol 1992; 38: 278.
26. Balsano C, Billet O, Bennoun M, Cavard C, Zider A. The hepatitis B virus X gene product transactivates the HIV-LTR in vivo. Arch Virol Suppl 1993; 8: 63.
27. Twu JS, Wu JY, Robinson WS. Transcriptional activation of the human immunodeficiency virus type 1 long terminal repeat by hepatitis B virus X-protein requires de novo protein synthesis. Virology 1990; 177: 406.
28. Levrero M, Balsano C, Natoli G, Avantaggiati ML. Hepatitis B virus X protein transactivates the long terminal repeats of hu-man immunodeficiency virus types 1 and 2. J Virol 1990; 64: 3082.
29. Laure F, Chatenoud L, Pasquinelli C, Gazengel C, Beaurain G, Torchet MF, et al. Frequent lymphocytes infection by hepatitis B virus in haemophiliacs. Br J Haematol 1987; 65: 181.
30. Kimberlin DW, Whitley RJ. Human herpesvirus-6: neurologic implications of a newly-described viral pathogen. J Neurol Virol 1998; 4: 474.
31. Wang F-Z, Linde A, Hagglund H, Testa M, Locasciulli A, Ljungman P. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis 1999; 28: 562.
32. Paterson DL, Singh N, Gayowski T, Carrigan DR, Marino IR. Encephalopathy associated with human herpesvirus 6 in a liver transplant recipient. Liver Transpl Surg 1999; 5: 454.
33. Mookerjee BF, Vogelsang G. Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplant 1997; 20: 905.
34. Cole PE, Stiles J, Boulad R, Small TN, O'Reilly J, George D, et al. Successful treatment of human herpesvirus 6 encephalitis in a bone marrow transplant recipient. Clin Infect Dis 1998; 27: 653.
35. Dockrell DH, Mendez JC, Jones M, Harmsen WS, Ilstrup DM, Smith TF, et al. Human herpesvirus 6 seronegativity before transplantation predicts the occurrence of fungal infection in liver transplant recipients. Transplantation 1999; 67: 399.
36. Flamand L, Gosselin J, Stefanescu I, Ablashi D, Menezes J. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 1995; 85: 1263.
37. Burd EM, Carrigan DR. Human herpesvirus 6 (HHV-6) associated dysfunction of blood monocytes. Virus Res 1993; 29: 79.
38. Roberts JP, Ascher NL, Lake J, Capper J, Purohit S, Garovoy M, et al. Graft versus host disease after liver transplantation in humans: a report of four cases. Hepatology 1991; 14: 274.
39. DePaoli AM, Bitran J. Graft versus host disease and liver transplantation. Ann Intern Med 1992; 117: 170.
40. Collins RH, Cooper B, Nikaein, Klintmalm GB, Fay JW. Graftversus-host disease in a liver transplant recipient. Ann Intern Med 1992; 116: 391.
41. Appleton AL, Sviland L, Peiris JSM, Taylor CE, Wilkes J, Green MA, et al. Human herpes virus-6 infection in marrow graft recipients: role in pathogenesis of graft-versus-host disease. Newcastle Upon Tyne Bone Marrow Transport Group. Bone Marrow Transplant 1995; 16: 777.
42. Wilborn F, Brinkman V, Schmidt CA, Neipel F, Gelderblom H, Siegert W. Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood 1994; 83: 3052.
43. Brown, NA, Sumaya, C V, Liu, C R, et. al. Fall in human herpesvirus-6 seropositivity with age[Letter]. Lancet 1988; 13: 396.